The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
Titel:
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
Auteur:
Finn, Richard S Crown, John P Lang, Istvan Boer, Katalin Bondarenko, Igor M Kulyk, Sergey O Ettl, Johannes Patel, Ravindranath Pinter, Tamas Schmidt, Marcus Shparyk, Yaroslav Thummala, Anu R Voytko, Nataliya L Fowst, Camilla Huang, Xin Kim, Sindy T Randolph, Sophia Slamon, Dennis J